Who is sponsoring NCT01720485?

NCT01720485 is sponsored by EMS.

What condition does NCT01720485 study?

NCT01720485 studies Allergic Rhinitis.

What drugs are being tested in NCT01720485?

Interventions: Desloratadine + Prednisolone, Dexchlorpheniramine + Betamethasone.

What is the status of NCT01720485?

NCT01720485 is currently UNKNOWN.

Last reviewed 2013-09-24 · How we verify

A Double-blind,Double Dummy, Randomized, Multicenter Parallel-group Study on Efficacy of Desloratadine and Prednisolone Association Compared to Dexchlorpheniramine and Betamethasone Association in Adults With Moderate - Severe Persistent Allergic Rhinitis

NCT01720485 Phase 3 UNKNOWN

The purpose of this study is to evaluate the non-inferiority clinical efficacy of two different drug associations in the treatment of Moderate - Severe Persistent Allergic Rhinitis in Adults.

Details

Lead sponsor	EMS
Phase	Phase 3
Status	UNKNOWN
Enrolment	234
Start date	2013-10
Completion	2014-03

Conditions

Allergic Rhinitis

Interventions

Desloratadine + Prednisolone
Dexchlorpheniramine + Betamethasone

Primary outcomes

Efficacy of treatment in persistent allergic rhinitis based on nasal symptoms score — 7 days
The mean variability of nasal symptoms score observed between visit 1 and visit 2 will be used as the primary endpoint of clinical efficacy.

Countries

Brazil